Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Differential Impact of Plasma Homocysteine Levels on the Periventricular and Subcortical White Matter Hyperintensities on the Brain.

Lee KO, Woo MH, Chung D, Choi JW, Kim NK, Kim OJ, Oh SH.

Front Neurol. 2019 Nov 7;10:1174. doi: 10.3389/fneur.2019.01174. eCollection 2019.

2.

The Protective Role of Feruloylserotonin in LPS-Induced HaCaT Cells.

He Y, Kim BG, Kim HE, Sun Q, Shi S, Ma G, Kim Y, Kim OS, Kim OJ.

Molecules. 2019 Aug 23;24(17). pii: E3064. doi: 10.3390/molecules24173064.

3.

Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an Aβ1-40-injected mouse model of Alzheimer's disease.

Park J, Lee SY, Shon J, Kim K, Lee HJ, Kim KA, Lee BY, Oh SH, Kim NK, Kim OJ.

Cytotherapy. 2019 Jun;21(6):671-682. doi: 10.1016/j.jcyt.2019.04.054. Epub 2019 May 7.

PMID:
31076196
4.

Association study of miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with venous thromboembolism in a Korean population.

Kim JO, Kim HW, An HJ, Kim OJ, Oh J, Chong SY, Choi WI, Oh D, Kim NK.

J Thromb Thrombolysis. 2019 Feb;47(2):255-262. doi: 10.1007/s11239-018-1778-z.

PMID:
30637557
5.
6.

Factors contributing to anxiety and depressive symptoms in adults with new-onset epilepsy.

Lee SA, Jeon JY, No SK, Park H, Kim OJ, Kwon JH, Jo KD.

Epilepsy Behav. 2018 Nov;88:325-331. doi: 10.1016/j.yebeh.2018.10.005. Epub 2018 Oct 17.

PMID:
30340902
7.

Alteration of microRNA 340-5p and Arginase-1 Expression in Peripheral Blood Cells during Acute Ischemic Stroke.

Yoo H, Kim J, Lee AR, Lee JM, Kim OJ, Kim JK, Oh SH.

Mol Neurobiol. 2019 May;56(5):3211-3221. doi: 10.1007/s12035-018-1295-2. Epub 2018 Aug 15.

PMID:
30112629
8.

Tonic Upward Eyeball Deviation Mimicking Non-Convulsive Occipital Lobe Status Epilepticus That Was Induced by Hydrocephalus.

Woo MH, Shin JW, Oh SH, Kim OJ.

J Epilepsy Res. 2018 Jun 30;8(1):49-53. doi: 10.14581/jer.18008. eCollection 2018 Jun.

9.

Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase.

Choi BY, Kim OJ, Min SH, Jeong JH, Suh SW, Chung TN.

Stem Cells Int. 2018 May 2;2018:1658195. doi: 10.1155/2018/1658195. eCollection 2018.

10.

The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model.

Choi C, Kim HM, Shon J, Park J, Kim HT, Kang SH, Oh SH, Kim NK, Kim OJ.

Cytotherapy. 2018 Jun;20(6):820-829. doi: 10.1016/j.jcyt.2018.04.004.

PMID:
29776835
11.

Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke model.

Oh SH, Choi C, Noh JE, Lee N, Jeong YW, Jeon I, Shin JM, Kim JH, Kim HJ, Lee JM, Kim HS, Kim OJ, Song J.

Exp Mol Med. 2018 Apr 13;50(4):22. doi: 10.1038/s12276-018-0041-1.

12.

Administration of placenta-derived mesenchymal stem cells counteracts a delayed anergic state following a transient induction of endogenous neurogenesis activity after global cerebral ischemia.

Kho AR, Kim OJ, Jeong JH, Yu JM, Kim HS, Choi BY, Suh SW, Chung TN.

Brain Res. 2018 Jun 15;1689:63-74. doi: 10.1016/j.brainres.2018.03.033. Epub 2018 Apr 3.

PMID:
29625115
13.

Additional increased effects of mannitol-temozolomide combined treatment on blood-brain barrier permeability.

Choi C, Kim HM, Shon J, Park J, Kim HT, Oh SH, Kim NK, Kim OJ.

Biochem Biophys Res Commun. 2018 Mar 4;497(2):769-775. doi: 10.1016/j.bbrc.2018.02.149. Epub 2018 Feb 17.

PMID:
29462622
14.

Association of MicroRNA Biogenesis Genes Polymorphisms with Ischemic Stroke Susceptibility and Post-Stroke Mortality.

Kim JO, Bae J, Kim J, Oh SH, An HJ, Han IB, Oh D, Kim OJ, Kim NK.

J Stroke. 2018 Jan;20(1):110-121. doi: 10.5853/jos.2017.02586. Epub 2018 Jan 31.

15.

Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.

Lee BI, No SK, Yi SD, Lee HW, Kim OJ, Kim SH, Kim MK, Kim SE, Kim YS, Kim JM, Lee SJ, Shin DJ, Park SP, Kim YI, Heo K, Cho YW, Cho YJ, Kim YN.

Seizure. 2018 Feb;55:17-24. doi: 10.1016/j.seizure.2017.12.008. Epub 2017 Dec 29.

16.

The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.

Park YS, An HJ, Kim JO, Kim WS, Han IB, Kim OJ, Kim NK, Kim DS.

Int J Mol Sci. 2017 Nov 21;18(11). pii: E2477. doi: 10.3390/ijms18112477.

17.

Real-time in vivo imaging of metastatic bone tumors with a targeted near-infrared fluorophore.

Lim W, Sohn H, Ko Y, Park M, Kim B, Jo D, Jung JS, Yang DH, Kim J, Kim OJ, Kim D, Moon YL, Min JJ, Hyun H.

Oncotarget. 2017 Aug 11;8(39):65770-65777. doi: 10.18632/oncotarget.20187. eCollection 2017 Sep 12.

18.

Interplay between 3'-UTR polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene and the risk of ischemic stroke.

Kim JO, Park HS, Ryu CS, Shin JW, Kim J, Oh SH, Kim OJ, Kim NK.

Sci Rep. 2017 Sep 29;7(1):12464. doi: 10.1038/s41598-017-12668-x.

19.

Predictors of disclosure management behavior at the end of 1-year follow-up in Korean adults with newly diagnosed epilepsy.

Lee SA, No SK, Park H, Kim OJ, Kwon JH, Ryu JY, Lee SM, Jo KD.

Epilepsy Behav. 2017 Sep;74:94-98. doi: 10.1016/j.yebeh.2017.06.020. Epub 2017 Jul 18.

PMID:
28732261
20.

Redefining periodic patterns on electroencephalograms of patients with sporadic Creutzfeldt-Jakob disease.

Shin JW, Yim B, Oh SH, Kim NK, Lee SK, Kim OJ.

Clin Neurophysiol. 2017 May;128(5):756-762. doi: 10.1016/j.clinph.2017.01.019. Epub 2017 Feb 5.

PMID:
28319876

Supplemental Content

Loading ...
Support Center